ALECR Eurofins-Cerep SA

16452.00USD15000.00 EUR · EPA0.00%Mkt Cap: 82.98M USDP/E: 9.74

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound man…

Key Statistics

Company
Market Cap82.98M USD
Enterprise Value—
Revenue (TTM)45.08M USD
Gross Profit24.04M USD
Net Income (TTM)5.25M USD
Revenue/Share—
Last Price16452.00 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0013256518
Valuation
P/E (Trailing)9.74
P/E (Forward)—
PEG3.26
EV/EBITDA—
EV/Revenue—
P/S1.84
P/B—
EPS (TTM)1689.23 USD
EPS (Forward)—
52W Range
16452.000% of range20400.48
52W High20400.48 USD
52W Low16452.00 USD
Profitability
Gross Margin53.49%
Oper. Margin8.19%
EBITDA Margin13.94%
Profit Margin11.67%
ROE6.25%
ROA5.37%
ROIC6.47%
ROCE4.55%
Growth
Revenue Growth10.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-23.07M USD
Net Debt/EBITDA-3.67
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio7.83
Quick Ratio7.53
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateJul 27, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.04K
Float—
Insiders95.78%
Institutions0.00%
Technical
SMA 5019672.20 (-16.4%)
SMA 20018438.30 (-10.8%)
Beta0.11
S&P 52W Chg12.00%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)8.2
MACD-390.7642
MACD Signal-20.6077
MACD Hist.-370.1566
BB Upper22103.81 USD
BB Middle19808.21 USD
BB Lower17512.61 USD
BB Width23.18%
ATR (14)284.79 USD
Vol Ratio (20d)0.00x

About Eurofins-Cerep (EPA: ALECR)

›

Eurofins-Cerep (EPA: ALECR) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector.

The shares were at 15000.00 EUR on 18 November 2026, down 6.8% over 52 weeks. Its 52-week range is 15000.00 EUR to 18600.00 EUR, and it trades at the bottom of that range.

At a market capitalisation of 75.66M EUR, it trades at 9.7 times trailing earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 73% for ALECR.

Eurofins-Cerep reports return on equity of 6.3%, an operating margin of 8.2% and revenue up 10.9% year over year.

It holds more cash than debt, a net cash position of 21.03M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.